Alginate biomaterial for the treatment of myocardial infarction: progress, translational strategies, and clinical outlook: from ocean algae to patient bedside

E Ruvinov, S Cohen - Advanced drug delivery reviews, 2016 - Elsevier
Alginate biomaterial is widely utilized for tissue engineering and regeneration due to its
biocompatibility, non-thrombogenic nature, mild and physical gelation process, and the …

The immune system and cardiac repair

NG Frangogiannis - Pharmacological research, 2008 - Elsevier
Myocardial infarction is the most common cause of cardiac injury and results in acute loss of
a large number of myocardial cells. Because the heart has negligible regenerative capacity …

Human mesenchymal stem cells stimulated by TNF-α, LPS, or hypoxia produce growth factors by an NFκB-but not JNK-dependent mechanism

PR Crisostomo, Y Wang, TA Markel… - … of Physiology-Cell …, 2008 - journals.physiology.org
Understanding the mechanisms by which adult stem cells produce growth factors may
represent an important way to optimize their beneficial paracrine and autocrine effects …

Conditioned media derived from mesenchymal stem cell cultures: The next generation for regenerative medicine

TNA Gunawardena, MT Rahman… - Journal of tissue …, 2019 - Wiley Online Library
Recent studies suggest that the main driving force behind the therapeutic activity observed
in mesenchymal stem cells (MSCs) are the paracrine factors secreted by these cells. These …

Enhanced engraftment, proliferation and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes

S Funakoshi, K Miki, T Takaki, C Okubo, T Hatani… - Scientific reports, 2016 - nature.com
Human pluripotent stem cell-derived cardiomyocytes (CMs) are a promising tool for cardiac
cell therapy. Although transplantation of induced pluripotent stem cell (iPSC)-derived CMs …

Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance

Z Cheng, L Ou, X Zhou, F Li, X Jia, Y Zhang, X Liu, Y Li… - Molecular Therapy, 2008 - cell.com
With the goal of devising a non-invasive cell therapy for cardiac repair that may be well
tolerated by patients with myocardial infarction (MI), this study evaluated the efficacy of …

Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression

YL Tang, W Zhu, M Cheng, L Chen, J Zhang… - Circulation …, 2009 - Am Heart Assoc
Myocardial infarction rapidly depletes the endogenous cardiac progenitor cell pool, and the
inefficient recruitment of exogenously administered progenitor cells limits the effectiveness …

Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 …

J Ringe, S Strassburg, K Neumann… - Journal of cellular …, 2007 - Wiley Online Library
The recruitment of bone marrow CD34− mesenchymal stem‐and progenitor cells (MSC) and
their subsequent differentiation into distinct tissues is the precondition for in situ tissue …

The mechanistic basis of infarct healing

NG Frangogiannis - Antioxidants & redox signaling, 2006 - liebertpub.com
Myocardial infarction triggers an inflammatory cascade that results in healing and
replacement of the damaged tissue with scar. Cardiomyocyte necrosis triggers innate …

SDF-1α as a therapeutic stem cell homing factor in myocardial infarction

SK Ghadge, S Mühlstedt, C Özcelik, M Bader - Pharmacology & …, 2011 - Elsevier
Myocardial infarction is associated with persistent muscle damage, scar formation and
depressed cardiac performance. Recent studies have demonstrated the clinical significance …